Continuous monitoring of toxicity in clinical trials - simulating the risk of stopping prematurely.
Aamot
H
H
Patient and Trials Office, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany. harald.aamot@nct-heidelberg.de
Gigic
B
B
Abel
U
U
Karapanagiotou-Schenkel
I
I
D001499:Bayes Theorem; D002986:Clinical Trials as Topic / Q000009:adverse effects / Q000379:methods; D006801:Humans; D011336:Probability; D012306:Risk